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Abstract   53 
Background: Observational studies in South Asian populations have suggested an 54 
association between vitamin B12 status and metabolic traits; however, the findings have been 55 
inconclusive. Hence, the aim of the present study was to use a genetic approach to explore the 56 
relationship between metabolic traits and vitamin B12 status in a Sri Lankan population and 57 
to investigate whether these relationships were modified by dietary intake.   58 
Methods: A total of 109 Sinhalese adults (61 men and 48 women aged 25-50 years), from 59 
Colombo city underwent anthropometric, biochemical, dietary intake analysis and genetic 60 
tests. Genetic risk scores (GRS) based on 10 metabolic single nucleotide polymorphisms 61 
(SNPs) (metabolic-GRS) and 10 vitamin B12 SNPs (B12-GRS) were constructed.  62 
Results: The B12-GRS was significantly associated with serum vitamin B12 (P=0.008), but 63 
not with metabolic traits (P>0.05); whereas, the metabolic-GRS had no effect on metabolic 64 
traits (P>0.05) and vitamin B12 concentrations (P>0.05). An interaction was observed 65 
between B12-GRS and protein energy intake (%) on waist circumference (P=0.002). 66 
Interactions were also seen between the metabolic-GRS and carbohydrate energy intake (%) 67 
on waist to hip ratio (P=0.015).  68 
Conclusion: Our findings suggest that a genetically lowered vitamin B12 concentration may 69 
have an impact on central obesity in the presence of a dietary influence; however, our study 70 
failed to provide evidence for an impact of metabolic-GRS on lowering B12 concentrations. 71 
Given that our study has a small sample size, further large studies are required to confirm our 72 
findings.  73 
 74 
Keywords: SNP, body mass index, obesity, metabolic traits, vitamin B12 pathway, 75 
Sinhalese, Sri Lanka, nutrigenetics 76 
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Introduction: 88 
 In recent years, the incidence of obesity in Sri Lanka has increased markedly [1]. The 89 
prevalence of being overweight or obese in Sri Lankan adults is 34.4% (25.2% and 9.2%, in 90 
2005 and 2006 respectively), with an upward trend being observed [1, 2]. Obesity increases 91 
the risk for certain health conditions, such as insulin resistance, diabetes mellitus and 92 
hypertension [3]. South Asians have been observed to exhibit increased visceral fat and waist 93 
circumference (WC), hyperinsulinemia and insulin resistance; this has been termed the 94 
‘South Asian phenotype’ [4]. Despite a known genetic contribution, the increase in obesity 95 
has been largely associated with changes in lifestyle habits [5, 6]. It is imperative that 96 
modifiable risk factors for obesity and associated metabolic problems are identified, 97 
especially if they can be easily addressed. 98 
Vitamin B12 is a micronutrient that has been identified as a modifiable risk factor 99 
associated with the progression of metabolic disorders. In humans, vitamin B12 acts as an 100 
essential co-enzyme involved in DNA synthesis and cellular energy production [7].  101 
Subclinical deficiency of vitamin B12 has been linked to higher levels of homocysteine; this 102 
may have important consequences in the progression of chronic diseases, by inducing 103 
oxidative stress and inflammation [8]. Vitamin B12 deficiency has also been linked to many 104 
other complications including an increased risk of obesity [9-11], diabetes [12-14] and 105 
cardiovascular disease [15]. Currently, one study has investigated the effect of genetically 106 
instrumented vitamin B12 concentrations on body mass index (BMI) in individuals with 107 
European ancestry; however, there were no associations between the vitamin B12 genetic risk 108 
score (GRS) and BMI [16].  109 
Genetic studies have implicated several gene loci in the predisposition to vitamin B12 110 
deficiency, but no study has yet been carried out in the Sri Lankan population [17].  The 111 
mechanisms by which obesity and its comorbidities are related to vitamin B12 deficiency are 112 
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poorly understood.  Hence, we conducted a gene-based approach to explore the relationship 113 
between metabolic traits and vitamin B12 status in a Sinhalese cohort, and investigated 114 
whether these relationships were modified by dietary intake in the Genetics Of Obesity and 115 
Diabetes (GOOD) study. 116 
 117 
Study Participants  118 
 The Genetics Of Obesity and Diabetes (GOOD) study is a cross-sectional study that 119 
was conducted in the city of Colombo, Sri Lanka, between April to August 2017. Healthy 120 
adults between the ages of 25-50 years were enrolled into the study. Exclusion criteria were: 121 
having a previous history of type 2 diabetes, cardiovascular disease or hypertension, having a 122 
BMI of more than 40 kg/m2 or being classed morbidly obese by a physician, being blood 123 
related to other participants in the study, having any communicable disease, being pregnant 124 
or lactating, taking dietary or vitamin supplements  and taking medications that affect lipid 125 
metabolism or hypertension (Figure 1).  126 
 The study was conducted in accordance with the principles of the Declaration of 127 
Helsinki and was approved by the Ethical Review Committee of the University of Colombo 128 
(EC-17-107) and the University of Reading Research Ethics Committee (17/25). All 129 
participants provided informed written consent before participating. 130 
 131 
Anthropometric Measures  132 
 Body weight was measured to the nearest 100 grams using an electronic scale (Seca 133 
815, Seca GmbH. Co. kg, Germany) and height was measured to the nearest millimeter using 134 
a stadiometer (Seca 217, Seca GmbH. Co. kg, Germany). The BMI calculation was based on 135 
the body weight (kg) divided by the square of body height (m). Waist circumference and hip 136 
circumference was measured using a metal tape (Lufkin W606PM®, Parsippany, NJ, USA). 137 
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Body fat percentage was estimated using a hand-held bio-electrical impedance analysis 138 
technique (Omron Body Fat Monitor BF306, Omron, Milton Keynes, United Kingdom).  139 
 140 
Biochemical Analysis  141 
 Blood samples (10 ml) were collected by a trained phlebotomist in the morning, after 142 
a 12 hour overnight fast. Fasting serum insulin and vitamin B12 levels were determined using 143 
the chemiluminescent microparticle immunoassay method on an Architect i1000 analyzer 144 
(Abbott Laboratories, IL, USA). Fasting plasma glucose concentrations were measured using 145 
the glucose hexokinase method using the Beckman Coulter AU5800 analyzer (Beckman 146 
Coulter®, California, United States). Glycated haemoglobin (HbA1c) was estimated by high-147 
performance liquid chromatography using the BioRad D10 HPLC analyser (Biorad, 148 
Hercules, CA, USA).  149 
 150 
Dietary intake analysis  151 
Dietary intakes were assessed using a previously validated and published [18] 152 
interviewer administered food frequency questionnaire (FFQ) containing 85 food items. In 153 
brief, participants were asked to estimate the usual frequency (number of times per day, week 154 
or month/never) and the portion sizes of various food items. The recorded data was analyzed 155 
with the NutriSurvey 2007 database (EBISpro, Germany) to estimate energy as well as 156 
macro- and micronutrient consumption[19].  157 
  “The Global Physical Activity Questionnaire” (GPAQ), developed by the World 158 
Health Organization (WHO) was used to measure physical activity [20]. Individuals were 159 
classified as vigorously active, when they both exercised and engaged in demanding work 160 
activities, and moderately active, when the participants either exercised or carried out heavy 161 
physical work. The remaining study participants were classified into the sedentary group. 162 
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SNP selection and Genotyping  163 
We selected 10 metabolic disease-related SNPs (associated with obesity and 164 
diabetes): Fat mass and obesity-associated [FTO]- rs9939609 and rs8050136, Melanocortin 4 165 
Receptor [MC4R]- rs17782313 and rs2229616, Transcription factor 7-like 2 [TCF7L2]- 166 
rs12255372 and rs7903146, Potassium voltage-gated channel subfamily J member 11 167 
[KCNJ11]- rs5219, Calpain 10 [CAPN10]- rs3792267, rs2975760 and rs5030952) for our 168 
analysis based on previously published candidate gene association and genome-wide 169 
association (GWA) studies for metabolic disease-related traits [21-29].  170 
The 10 vitamin B12-related SNPs (Methylenetetrahydrofolate reductase [MTHFR]- 171 
rs1801133, Carbamoyl-phosphate synthase 1 [CPS1]- rs1047891, Cubulin [CUBN]- 172 
rs1801222, CD320 molecule [CD320]- rs2336573, Transcobalamin 2 [TCN2]- rs1131603, 173 
Citrate lyase beta like [CLYBL]- rs41281112, Fucosyltransferase 2 [FUT2]- rs602662, 174 
Transcobalamin 1 [TCN1]- rs34324219, Fucosyltransferase 6 [FUT6]- rs778805 and 175 
Methylmalonyl-CoA mutase [MUT]- rs1141321) were chosen on the basis of the recent 176 
review article  by Surendran et al. [17].  177 
Blood samples for the measurement of DNA were transported in dry ice to the UK. 178 
Genomic DNA was extracted from a 5 ml whole blood sample from each participant and 179 
genotyping was performed at LGC Genomics 180 
(http://www.lgcgroup.com/services/genotyping), which employs the competitive allele-181 
specific PCR-KASP® assay. 182 
  The Hardy-Weinberg equilibrium (HWE) P values were computed for the following 183 
20 SNPs. The SNPs FUT2 rs602662 and CAP10 rs3792267 deviated from HWE; however, 184 
these SNPs were not excluded from analysis. The FUT2 SNP rs602662 previously departed 185 
from HWE in a GWA study conducted in India; the authors ruled out that the deviation was 186 
not due to a genotyping error and still used this SNP for analysis in their study [30]. In 187 
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addition, the KASPTM genotyping technology used in our study has been independently 188 
assessed to be over 99.8% accurate. Validation of the KASPTM genotyping was conducted at 189 
LGC genomics, where the genotyping results were assessed by two project managers 190 
separately to confirm that the data was accurate, and this ruled out genotyping artefacts as 191 
possible reasons for deviation from HWE. The reasons for deviation from HWE could be due 192 
to population or racial grouping substructure (Sub-grouping), non-random mating, linkage 193 
disequilibrium (incomplete mixing of different ancestral population) or chance findings [31]. 194 
 195 
Statistical Analysis 196 
The SPSS statistical package (version 22; SPSS Inc., Chicago, IL, USA) was used for 197 
the statistical analysis. Allele frequencies were estimated by gene counting (Table 1). The 198 
normality of variable distribution was verified by the Shapiro-Wilk test, and data not 199 
normally distributed were log transformed prior to analysis. We performed an independent t-200 
test to compare the means of the quantitative variables between men and women. Comparison 201 
of the means between the two groups was analyzed by the Chi Square test for categorical 202 
outcomes.  203 
A schematic representation of the study design is presented in figure 2. The 204 
unweighted, risk-allele GRS method was calculated for each participant as the sum of risk 205 
allele counts across each SNP which predicted vitamin B12 status or metabolic disease risk. 206 
The B12-GRS was generated from the SNPs in the genes MTHFR, CPS1, CUBN, CD320, 207 
TCN2, CLYBL, FUT2, TCN1, FUT6, MUT, which have been shown to be associated with 208 
vitamin B12 concentrations. Furthermore, another unweighted GRS was created using allele 209 
markers previously reported to be associated with metabolic disease traits. The metabolic-210 
GRS was generated from the SNPs in the genes CAP10, KCNJ11, TCF7L2, FTO and MC4R. 211 
A value of 0,1 or 2 was assigned to each SNP, which denotes the number of risk alleles on 212 
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that SNP. These values were then calculated by adding the number of risk alleles across each 213 
SNP. The average number of risk alleles per person for the B12-GRS was 8.69 (SD = 1.70), 214 
which ranged from 5 to 15. The sample was stratified, by the median, into a “low genetic risk 215 
group,” for those with a GRS ≤ 9 risk alleles (n = 79), and into a “high genetic risk group,” 216 
for those with a GRS ≥ 10 risk alleles (n = 30). For the metabolic-GRS, the average number 217 
of risk alleles per person was 7.00 (SD = 2.28), which ranged from 1 to 13. The sample was 218 
stratified, into a “low genetic risk group,” for those with a GRS ≤ 8 risk alleles (n = 88), and 219 
into a “high genetic risk group,” for those with a GRS ≥ 9 risk alleles (n = 21). Linear 220 
regression was used to examine the association of the two GRS scores with the biochemical 221 
and anthropometric outcomes (glucose, insulin, HbAC1, vitamin B12, body fat %, BMI, WC 222 
and WHR). The interaction between the two GRS scores and dietary factors on biochemical 223 
and anthropometric outcomes was determined by including interaction terms (GRS*diet) in 224 
the regression model. Models were adjusted for age, sex, BMI, and total energy intake, 225 
wherever appropriate.  226 
Correction for multiple testing was applied using Bonferroni correction [adjustment P 227 
value for association analysis was <0.00313 [2 GRS * 8 biochemical and anthropometric 228 
outcomes (Fasting blood glucose, fasting insulin, glycated haemoglobin, vitamin B12, Fat %, 229 
BMI, WC and WHR)=16 test)] and for interaction < 0.00078 [2 GRS * 8 biochemical and 230 
anthropometric * 4  lifestyle factors (dietary carbohydrate energy %, dietary protein energy 231 
%, dietary fat energy % and physical activity levels))= 64]. Given that there are no studies on 232 
GRS and no previously reported effect sizes for the South Asians, we were unable to perform 233 
a power calculation.  234 
Results  235 
Characteristics of the participants  236 
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In this study, 109 participants (mean age, 38.34 ± 6.92 years; BMI, 24.58 ± 4.12 237 
kg/m2) were included. Table 2 illustrates the main characteristics of the study participants 238 
stratified according to sex. No significant difference between men and women were observed 239 
in the levels of fasting glucose, insulin, HbAC1 and plasma vitamin B12 (P>0.05).  240 
Association between B12-GRS and Obesity GRS with biochemical and anthropometric 241 
measurements 242 
A significant association between B12-GRS and serum vitamin B12 was observed (P 243 
= 0.008) (Supplementary Table 1 and Figure 3); However, this finding was not significant 244 
after correction for multiple testing. No associations between the B12-GRS and metabolic 245 
traits (P > 0.05) were observed (Supplementary Table 1). Furthermore, no associations 246 
between the metabolic-GRS and vitamin B12 or metabolic traits (P>0.05) were observed 247 
(Supplementary Table 2). 248 
Interaction between the B12-GRS and dietary factors on biochemical and anthropometric 249 
measurements 250 
An interaction was found between the B12-GRS and protein energy (%) on log 251 
transformed WC (P=0.002). However, further stratification of participants based on their 252 
consumption of low, medium and high dietary protein (energy %) did not show statistically 253 
significant associations between the GRS and the outcome in any of the tertiles, which could 254 
account for the small sample size (Supplementary Table 3).  255 
Interaction between the metabolic-GRS and dietary factors on biochemical and 256 
anthropometric measurements 257 
We observed a significant interaction between the metabolic-GRS and carbohydrate 258 
energy intake (%) on waist to hip ratio (Pinteraction = 0.015) (Figure 4 and Table 3). 259 
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Individuals who carried 8 or less risk alleles for metabolic disease had 7.47 % lower WHR 260 
measurements (cm) in the highest tertile of carbohydrate energy intake (%) (Mean ± S.D: 261 
78.00 ± 7.90%) compared to those with 9 or more risk alleles (P= 0.035) (Table 3). 262 
Interactions were also seen between the metabolic-GRS and carbohydrate energy (%) 263 
on log fasting insulin concentrations (P=0.011) and log WC (P=0.031), and the metabolic-264 
GRS and protein energy (%) on log fasting insulin levels and (P= 0.032) and log WC 265 
(P=0.011) (Table 3 and Supplementary Table 3). 266 
Interaction between the B12-GRS and physical activity on biochemical and anthropometric 267 
measurements 268 
 No statistically significant interactions were observed between the two GRSs 269 
(vitamin B12 and metabolic) and physical activity on biochemical and anthropometric 270 
measurements (Table 3 and Supplementary Table 3). After correction for multiple testing, 271 
none of these gene-diet and gene-physical activity interactions remained statistically 272 
significant. 273 
Discussion: 274 
To our knowledge, this is the first study to use a genetic approach to explore the 275 
relationship between metabolic traits and vitamin B12 status in a South Asian population. 276 
Our study confirmed the strength of the association between B12-GRS and B12 277 
concentrations and demonstrated the impact of genetically instrumented B12 concentrations 278 
on waist circumference, an indicator of central obesity, through the influence of dietary 279 
protein intake. Furthermore, our study has also showed a significant effect of metabolic-GRS 280 
on waist to hip ratio through the influence of high carbohydrate intake. Given that the total 281 
daily intake of protein is low and carbohydrate is high in Sri Lankan adults [32], our findings, 282 
if replicated in future studies, might carry significant public health implications in terms of 283 
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revising the food-based dietary guidelines which could prevent central obesity and the 284 
associated CVD-related outcomes. 285 
In this study, we constructed a GRS consisting of ten vitamin B12 decreasing SNPs in 286 
genes involved in vitamin B12 metabolism [17]. The B12-GRS was associated with vitamin 287 
B12 levels, suggesting that it would be an ideal instrument for vitamin B12 status. Given the 288 
lack of association between the B12-GRS and metabolic disease traits in our study, we were 289 
unable to provide evidence for linear decreases in vitamin B12 concentrations having 290 
substantive effects on metabolic disease traits. However, we found a significant interaction 291 
between the B12-GRS and protein energy (%) on log WC. Interestingly, individuals who 292 
carried 9 or less alleles had lower WC when consuming a high protein diet compared to those 293 
consuming a low protein diet. Although no statistically significant differences in WC were 294 
observed between the alleles of the B12-GRS, the impact of the B12-GRS on WC was 295 
observed only under the influence of a high protein diet. Further investigations are required to 296 
confirm this finding to determine the clinical significance and potential applications as part of 297 
weight management interventions. 298 
At present, carbohydrates constitute the majority of the energy intake among South 299 
Asian countries such as Sri Lanka (~71.2%) [32]; in contrast, the consumption of 300 
carbohydrates is lower in Western countries (~45 %) [33]. Furthermore, high carbohydrate 301 
intake has been associated with an increased risk of diabetes in a South Indian population 302 
[34], and an increase in WC among pre-menopausal (20-45 years) Sri Lankan women [35]. In 303 
the present study, we found a significant interaction between the metabolic-GRS and 304 
carbohydrate energy percentage on waist-to-hip ratio, where the individuals carrying more 305 
than 9 risk alleles had a higher waist-to-hip ratio among those in the highest tertile of 306 
carbohydrate energy percentage. There are no previous reports of the risk variants used in our 307 
GRS, but Goni et al [36] found that carbohydrates (total and complex) interacted with a GRS 308 
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of 16 obesity/lipid metabolism polymorphisms to modify the effect on body fat mass in 711 309 
individuals of Caucasian ancestry. In our study, we only observed interactions of the 310 
metabolic-GRS on WC and waist-to-hip ratio, which suggests that effects are likely to be on 311 
central obesity as opposed to common obesity. 312 
South Asians have a higher risk of developing obesity related non-communicable 313 
diseases relative to white Caucasians despite lower BMI levels; this has been termed the 314 
‘South Asian phenotype’. The distinctive features of this phenotype include a higher WC, 315 
abdominal adiposity combined with insulin resistance, and a greater predisposition to 316 
diabetes [4]. The role of vitamin B12 in promoting this adverse phenotype has been 317 
suggested by Yajnik et al., who demonstrated that offspring born to mothers with a low 318 
vitamin B12  and high folate status had a greater risk of developing insulin resistance during 319 
childhood [12]. According to Yajnik et al., vitamin B12 deficiency prevents the generation of 320 
tetrahydrofolate from 5-methyltetrahydrofolate in the one-carbon metabolism cycle; as a 321 
result, homocysteine levels accumulate leading to altered lean tissue deposition and reduced 322 
protein synthesis [12]. Furthermore, vitamin B12 is involved in the conversion of 323 
methylmalonyl-CoA to succinyl-CoA by the enzyme methylmalonyl-CoA mutase (adenosyl-324 
B12 as a cofactor). Subsequently, vitamin B12 deficiency results in elevated methylmalonyl-325 
CoA, inhibiting the mitochondrial enzyme carnitine palmitoyltransferase, which may 326 
promote lipogenesis and insulin resistance [12, 37].   327 
No studies to date, have investigated interactions between the two GRSs and physical 328 
activity on metabolic traits and B12 concentrations in Asian Sri Lankans. Although, 60% of 329 
Sri Lankan adults are reported to be highly physically active [38], no significant interactions 330 
were found between the two GRSs and physical activity on metabolic traits, which could be 331 
due to a small sample size and measurement bias associated with self-reported physical 332 
activity questionnaire. The strengths of our study include the use of a validated food 333 
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frequency questionnaire [18] to measure macronutrient intake, the comprehensive 334 
measurements of lifestyle factors, and the use of GRSs which increased the statistical power 335 
of our study [39]. Nevertheless, some limitations need to be acknowledged. The first 336 
limitation concerns the relatively small sample size of the study, however, we were still able 337 
to identify significant gene-diet interactions. Furthermore, we used Bonferroni correction to 338 
correct for multiple testing and this can often lead to larger power, specifically where studies 339 
have a small sample size and a small number of disease-associated markers. This is also true 340 
for when studies have a large allele frequency difference due to a small sample size [40].  341 
Secondly, information about the type of oil used for frying, the estimation of different dietary 342 
fat components (monounsaturated or saturated fatty acids) and vitamin B12 intake was not 343 
collected. This could have limited our in-depth analysis of interactions of specific 344 
macronutrients and vitamins with the two GRSs. Furthermore, the study was limited to 345 
Sinhalese adults in Colombo, and the conclusions may not be applicable to other ethnic 346 
groups in Sri Lanka. Finally, none of the genetic associations or gene-lifestyle interactions 347 
were statistically significant after correction for multiple testing; however, given that this is 348 
the first study using a genetic approach to establish a relationship between vitamin B12 status 349 
and metabolic disease outcomes in South Asians, we have taken into consideration of the 350 
significant findings; hence, further large studies are required to replicate our findings. 351 
In summary, our study suggests that a genetically lowered vitamin B12 concentration 352 
may have an impact on central obesity in the presence of a dietary influence; however, our 353 
study failed to show an impact of the metabolic-GRS on lowering B12 concentrations 354 
through a dietary influence. Our study also showed a significant effect of the metabolic-GRS 355 
on waist to hip ratio, another indicator of central obesity, through the influence of a high 356 
carbohydrate intake. However, after correction for multiple testing, none of these findings 357 
17 
 
were statistically significant. Hence, further replication studies are highly warranted on large 358 
samples to confirm or refute our findings. 359 
360 
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Figure legends 401 
 402 
Figure 1 Flow chart of the subject recruitment process 403 
Figure 2 Diagram representing the study design. The diagram shows four possible 404 
associations, and four possible interactions. One-sided arrows with unbroken lines represent 405 
genetic associations and one-sided arrows with broken lines represent interactions between a 406 
lifestyle factor and GRS on serum vitamin B12/ metabolic traits.  We tested the association 407 
between the metabolic-GRS and vitamin B12 concentrations and metabolic disease-related 408 
traits. We then tested the associations between the B12 –GRS and vitamin B12 status and 409 
metabolic disease related traits. Lastly, we tested whether these genetic associations were 410 
modified by lifestyle factors (macronutrient intake and physical activity levels).  411 
Figure 3 Association between the B12-GRS and serum vitamin B12 levels. Vitamin B12 412 
decreasing alleles ranged from 5 to 15. Individuals with ≤9 or ≥10 alleles were grouped to 413 
obtain a reasonable number of individuals in each group. 414 
 Figure 4 Interaction between the metabolic-GRS and carbohydrate energy intake (%) 415 
on waist-to-hip ratio (cm) (Pinteraction = 0.015). Among those who consumed a high 416 
carbohydrate diet, individuals who carried 9 or more risk alleles had significantly higher 417 
levels of waist-to-hip ratios compared to individuals carrying 8 or less risk alleles (P = 0.035) 418 
 419 
 420 
 421 
 422 
 423 
 424 
 425 
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Table 1: Genotype distribution of vitamin B12 related SNPs and metabolic disease-related SNPs 
 
Gene rs number Major 
allele 
Minor 
allele 
Common 
Homozygotes  
(%) 
Heterozygotes 
(%) 
Rare 
Homozygotes  
(%) 
Minor 
allele 
frequency 
HWE P 
value 
 
MTHFR rs1801133 C T 89 (81.7) 19 (17.4) 1 (0.9) 0.100 0.990 
CPS1 rs1047891 C A 56 (51.9) 44 (40.7) 8 (7.4) 0.278 0.873 
CUBN rs1801222 C T 78 (72.2) 29 (26.9) 1 (0.9) 0.144 0.338 
CD320 rs2336573 C T 99 (90.8) 10 (9.2) 0 (0) 0.046 0.616 
TCN2 rs1131603 T C 107 (98.2) 2 (1.8) 0 (0) 0.009 0.923 
CLYBL rs41281112 C T 105 (96.3) 4 (3.7) 0 (0) 0.018 0.845 
FUT2 rs602662 G A 60 (55.6) 30 (27.8) 18 (16.7) 0.306 0.000 
TCN1 rs34324219 C A 107 (98.2) 2 (1.8) 0 (0) 0.009 0.923 
FUT6 rs778805 C T 29 (26.6) 53 (48.6) 27 (24.8) 0.491 0.776 
MUT rs1141321 G A 28 (25.7) 60 (55.0) 21 (19.3) 0.470 0.271 
CAPN10 rs3792267 G A 79 (72.5) 24 (22.0) 6 (5.5) 0.165 0.035 
CAPN10 rs2975760 T C 66 (60.6) 38 (34.9) 5 (4.6) 0.220 0.874 
CAPN10 rs5030952 C T 101 (92.7) 8 (7.3) 0 (0) 0.037 0.691 
KCNJ11 rs5219 C T 49 (45.0) 45 (41.3) 15 (13.8) 0.344 0.373 
TCF7L2 rs12255372 G T 57 (52.3) 45 (41.3) 7 (6.4) 0.271 0.633 
TCF7L2 rs7903146 C T 45 (41.3) 54 (49.5) 10 (9.2) 0.340 0.274 
FTO rs9939609 T A 48 (44.0) 47 (43.1) 14 (12.8) 0.344 0.641 
MCR rs17782313 T C 48 (44.0) 50 (45.9) 11 (10.1) 0.330 0.700 
FTO rs8050136 C A 48 (44.0) 47 (43.1) 14 (12.8) 0.340 0.641 
MC4R rs2229616 G A 99 (91.7) 9 (8.3) 0 (0) 0.042 0.651 
 
MAF; minor allele frequency, HWE; Hardy Weinberg Equilibrium, X2; Chi-Squared value 
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Table 2: Anthropometric and biochemical characteristics of men and women 
participants (n=109, Men 61: women 48) 
  
 
Total (n=109) Men (n=61) Women (n=48) 
 
 
P value* 
 Mean ± SD Mean ± SD Mean ± SD  
Age (yrs) 38.24  ± 6.92 37.34 ± 6.97 39.38 ± 6.77 0.129 
Height (cm) 164.97 ± 9.15 170.95 ± 6.18 157.36 ± 6.16 <0.0001 
Weight (kg) 67.07 ± 13.05 71.76 ± 11.81 61.11 ± 12.17 <0.0001 
BMI (kg/m2) 24.58 ± 4.12 24.51 ± 3.52 24.68 ± 4.80 0.844 
Waist circumference (cm) 83.73 ± 17.97 89.83 ± 14.04 75.99 ± 19.52 <0.0001 
Hip circumference (cm) 91.16 ± 17.78 92.27 ± 13.83 89.75 ± 21.87 0.488 
WHR 0.92 ± 0.11 0.98 ± 0.08 0.85 ± 0.11 <0.0001 
Fat (%) 27.25 ± 7.37 23.52 ± 5.12 32.00 ± 7.08 <0.0001 
Obesity cases** 40.37% 37.70% 43.75% 0.523 
Fasting Blood Glucose (mg/dL) 85.64  ± 12.64 87.41 ± 15.41 83.40 ± 7.40 0.100 
Fasting Blood Insulin (pmol/L) 68.55 ± 49.97 71.77 ± 59.12 64.46 ± 35.28 0.451 
Fasting Blood HbA1C (mmol/mol) 35.62  ± 5.91 35.20 ± 5.99 36.16 ± 5.84 0.402 
Fasting Blood B12 (pmol/L) 380.65  ± 132.83 389.80 ±  135.00 369.02 ± 130.52 0.420 
Physical Activity Levels  
(Low%/ moderate%/ high%) 
72.5/ 19.3/ 8.3 
 
70.5/19.7/9.8 75.0/18.8/6.3 
0.777 
Total energy (kcal/d) 2097.92  ± 456.01 2173.68 ± 427.82 2001.65 ± 476.72 0.050 
Protein (energy %) 11.29 ± 2.31 11.25 ± 2.41 11.33 ± 2.20 0.853 
Fat (energy %) 21.87 ± 5.31 21.64 ± 5.22 22.16 ± 5.45 0.613 
Carbohydrate (energy %) 69.62 ± 8.80 69.89 ± 10.29 69.28 ± 6.52 0.721 
Dietary fibre (g) 16.78  ± 8.18 17.24 ± 8.46 16.20 ± 7.85 0.513 
Polyunsaturated fatty acids  (g) 3.32  ± 1.69 3.36 ± 1.66 3.27 ± 1.75 0.779 
 
Abbreviations: BMI Body mass index; SD indicates standard deviations; WHR, waist to hip ratio 
Data presented as Mean ± SD 
* P < 0.05, statistically significant differences in mean values between men/women, unadjusted 
**Obesity cases refers to the percentage of individuals with a BMI of over 25. 
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 Table 3: Interaction between the B12-GRS and lifestyle factors on anthropometric 
measurements 
Interaction between the GRS and lifestyle factors on Log waist circumference (cm) 
Interaction between 
B12-GRS * fat energy 
%  
Interaction between 
B12-GRS * protein 
energy % 
Interaction between B12-
GRS * carbohydrate 
energy % 
Interaction between 
B12-GRS * Physical 
activity levels 
0.002 ± 0.004  
(0.727) 
0.037 ± 0.011 
(0.002) 
-0.003 ± 0.003  
(0.344) 
 
-0.051 + 0.037 
(0.173) 
Interaction between 
metabolic-GRS * fat 
energy %  
Interaction between 
metabolic-GRS * 
protein energy % 
Interaction between 
metabolic-GRS * 
carbohydrate energy % 
Interaction between 
metabolic-GRS * 
Physical activity 
levels 
-0.007 ± 0.006  
(0.212) 
-0.024 ± 0.009 
(0.011) 
0.007 ± 0.003  
(0.031) 
0.020 ± 0.044 
(0.654) 
Interaction between the GRS and dietary factors on waist to hip ratio 
Interaction between 
B12-GRS * fat energy 
%  
Interaction between 
B12-GRS * protein 
energy % 
Interaction between B12-
GRS * carbohydrate 
energy % 
Interaction between-
B12 GRS * Physical 
activity levels 
0.002 ± 0.004 
(0.660) 
0.013 ± 0.010 
(0.196) 
-0.003 ± 0.002  
(0.241) 
0.018 ± 0.032 
(0.584) 
Interaction between 
metabolic-GRS * fat 
energy %  
Interaction between 
metabolic-GRS * 
protein energy % 
Interaction between 
metabolic-GRS * 
carbohydrate energy % 
Interaction between 
metabolic-GRS * 
Physical activity 
levels 
-0.009 ± 0.005 
(0.079) 
-0.012 ± 0.008 
(0.158) 
0.007 ± 0.003 
(0.015) 
0.038 ± 0.039 
(0.323) 
Interaction between the GRS and lifestyle factors on Log BMI 
Interaction between 
B12-GRS * fat energy 
%  
Interaction between 
B12-GRS * protein 
energy % 
Interaction between B12-
GRS * carbohydrate 
energy % 
Interaction between 
B12-GRS * Physical 
activity levels 
-0.002 ± 0.003 
(0.539†) 
0.009 ± 0.008 
(0.259†) 
-0.001 ± 0.002 
(0.762†) 
0.015 ± 0.023 
(0.513†) 
Interaction between 
metabolic-GRS * fat 
energy %  
Interaction between 
metabolic-GRS * 
protein energy % 
Interaction between 
metabolic-GRS * 
carbohydrate energy % 
Interaction between 
metabolic-GRS * 
Physical activity 
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Values are beta coefficients ± standard errors. P values are inserted in brackets 
P values were obtained by using a general linear model adjusted for age, sex and BMI  
† P values were obtained by using a general linear model adjusted for age and sex 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
levels 
-0.004 ± 0.004 
(0.245†) 
-0.004 ± 0.006 
(0.480†) 
0.002 ± 0.002 
(0.322†) 
-0.005 ± 0.028 
(0.851†) 
